The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/26088

Title:	The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients.
Authors:	Garzotto, F Ostermann, M Martín-Langerwerf, D Sánchez-Sánchez, M Teng, J Robert, R Marinho, A Herrera-Gutierrez, M E Mao, H J Benavente, D Kipnis, E Lorenzin, A Marcelli, D Tetta, C Ronco, C View more
Keywords:	AKI Critical illness Fluid overload ICU RRT View more
Mesh:	Acute Kidney Injury Adult Aged Critical Illness Female Follow-Up Studies Humans Intensive Care Units Male Middle Aged Prospective Studies Renal Replacement Therapy Risk Factors Water-Electrolyte Imbalance Dose-Response Relationship, Drug View more
Issue Date:	23-Jun-2016
Citation:	Crit Care.2016 Jun;(20)1:196
Abstract:	The previously published "Dose Response Multicentre International Collaborative Initiative (DoReMi)" study concluded that the high mortality of critically ill patients with acute kidney injury (AKI) was unlikely to be related to an inadequate dose of renal replacement therapy (RRT) and other factors were contributing. This follow-up study aimed to investigate the impact of daily fluid balance and fluid accumulation on mortality of critically ill patients without AKI (N-AKI), with AKI (AKI) and with AKI on RRT (AKI-RRT) receiving an adequate dose of RRT.
PMID:	27334608
URI:	https://hdl.handle.net/20.500.12530/26088
Rights:	openAccess
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos Hospitales > H. U. La Paz > Artículos

Files in This Item:

File	Description	Size	Format
PMC4918119.pdf		2.47 MB	Adobe PDF	View/Open